Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TDTF | 0.07% | $814.22M | 0.18% |
JSI | -0.15% | $835.88M | 0.49% |
SCHP | 0.24% | $12.77B | 0.03% |
MMIT | -0.24% | $848.85M | 0.3% |
VMBS | 0.34% | $14.41B | 0.03% |
ISTB | -0.35% | $4.43B | 0.06% |
FMHI | 0.35% | $755.21M | 0.7% |
FTSM | -0.39% | $6.43B | 0.45% |
JMBS | 0.39% | $5.50B | 0.22% |
BSMR | 0.49% | $255.46M | 0.18% |
CANE | -0.54% | $9.94M | 0.29% |
CGCB | -0.69% | $2.36B | 0.27% |
JMST | -0.74% | $3.96B | 0.18% |
YEAR | 0.83% | $1.44B | 0.25% |
TIPX | -0.85% | $1.65B | 0.15% |
CORN | 0.86% | $47.63M | 0.2% |
FMB | 0.87% | $1.90B | 0.65% |
IBTF | 0.93% | $2.08B | 0.07% |
GTIP | 0.95% | $159.02M | 0.12% |
DFIP | 0.98% | $908.19M | 0.11% |
Finnhub
Presenter SpeechUnknown Analyst All right. Good morning. Good afternoon, everyone. Thanks for joining us here at the Goldman Sachs Healthcare Conference. Thrilled to be joined today by Arthur Kuan...
Yahoo
IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that Arthur Kuan, Chairman & Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, June 10, 2025, at 11:20 am ET. Interested pa
Yahoo
CG Oncology stock surges 27% in a month following superior efficacy data from its phase III study of cretostimogene for a bladder cancer indication.
Yahoo
IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that management will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference in New York, NY on Tuesday, May 20, 2025, at 11:30 am ET. Interested parties can access the live audio webcast for
Yahoo
CG Oncology, Inc. (CGON) delivered earnings and revenue surprises of -15.38% and 90.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
- Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete response rate of 42.3% by K-M -- Promising early signal in Cohort P with 90.5% high-grade recurrence free survival at 3 and 9 months by K-M -- New enrollment completion date for Phase 3 PIVOT-006 in intermediate-risk non-muscle invasive bladder cancer (NMIBC) expected in the second half of 2025 -- Initiated CORE-008 Cohort CX evaluating the combination
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -44.55% | $104.89M | 0.59% |
VIXY | -41.98% | $181.73M | 0.85% |
BTAL | -39.58% | $291.96M | 1.43% |
IVOL | -25.11% | $358.40M | 1.02% |
FTSD | -19.08% | $228.58M | 0.25% |
SPTS | -15.79% | $5.78B | 0.03% |
XONE | -15.47% | $639.82M | 0.03% |
SCHO | -14.78% | $10.95B | 0.03% |
CTA | -13.98% | $1.09B | 0.76% |
ULST | -13.58% | $667.54M | 0.2% |
VGSH | -13.10% | $22.51B | 0.03% |
UTWO | -12.79% | $375.31M | 0.15% |
SHYM | -12.65% | $324.56M | 0.35% |
IBTH | -12.30% | $1.58B | 0.07% |
STPZ | -11.70% | $452.13M | 0.2% |
LDUR | -10.82% | $917.46M | 0.5% |
IBTI | -10.77% | $1.04B | 0.07% |
IEI | -10.37% | $15.30B | 0.15% |
IBTJ | -9.24% | $678.03M | 0.07% |
FXY | -9.15% | $862.15M | 0.4% |
Current Value
$26.131 Year Return
Current Value
$26.131 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 67.75% | $4.76B | 0.35% |
IBB | 63.42% | $5.43B | 0.45% |
GNOM | 60.58% | $44.57M | 0.5% |
PBE | 57.38% | $226.09M | 0.58% |
ARKG | 56.20% | $974.51M | 0.75% |
IWO | 56.01% | $11.29B | 0.24% |
PTH | 55.96% | $103.32M | 0.6% |
FBT | 55.71% | $1.03B | 0.54% |
IWC | 55.03% | $810.66M | 0.6% |
KJUL | 54.99% | $119.49M | 0.79% |
XPH | 54.92% | $153.44M | 0.35% |
VTWO | 54.85% | $12.36B | 0.07% |
IWM | 54.77% | $64.27B | 0.19% |
BBH | 54.51% | $341.71M | 0.35% |
SCHA | 54.40% | $17.04B | 0.04% |
ISCG | 54.00% | $667.95M | 0.06% |
ESML | 53.38% | $1.82B | 0.17% |
SMMD | 53.31% | $1.43B | 0.15% |
VBK | 53.27% | $18.61B | 0.07% |
KJAN | 53.21% | $289.07M | 0.79% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -15.90% | $23.54M | -75.48% | 0.00% |
FMTO | -14.79% | $4.90K | -99.92% | 0.00% |
CBOE | -11.03% | $23.65B | +34.73% | 1.12% |
ED | -7.78% | $37.46B | +14.41% | 3.24% |
AQB | -7.06% | $3.14M | -53.66% | 0.00% |
VHC | -6.66% | $36.37M | +130.03% | 0.00% |
TDUP | -6.46% | $863.20M | +305.56% | 0.00% |
KR | -6.34% | $43.65B | +30.13% | 1.95% |
BTCT | -5.04% | $19.24M | +37.16% | 0.00% |
AGRO | -5.01% | $928.94M | +2.65% | 3.74% |
NEUE | -4.88% | $61.16M | +27.09% | 0.00% |
CL | -4.58% | $73.15B | -4.61% | 2.23% |
AMT | -4.40% | $100.56B | +9.02% | 3.86% |
MO | -4.40% | $100.75B | +34.95% | 6.89% |
MCK | -3.32% | $91.11B | +23.43% | 0.39% |
AWK | -3.29% | $27.58B | +9.39% | 2.19% |
BTI | -2.74% | $106.90B | +59.32% | 6.19% |
UUU | -2.56% | $7.19M | +93.17% | 0.00% |
EXC | -2.50% | $43.66B | +21.69% | 3.61% |
DOGZ | -2.49% | $366.64M | +64.85% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IDYA | 58.59% | $1.94B | -41.80% | 0.00% |
SYRE | 57.11% | $1.04B | -45.13% | 0.00% |
ACLX | 54.40% | $3.64B | +21.30% | 0.00% |
NUVL | 54.09% | $5.62B | +0.59% | 0.00% |
CRNX | 53.20% | $2.98B | -29.91% | 0.00% |
IMVT | 52.56% | $2.68B | -39.77% | 0.00% |
KRYS | 51.95% | $3.96B | -22.90% | 0.00% |
SNDX | 51.73% | $881.99M | -49.03% | 0.00% |
COGT | 51.71% | $806.10M | -15.96% | 0.00% |
LFUS | 51.59% | $5.34B | -14.74% | 1.28% |
XNCR | 51.48% | $654.06M | -55.34% | 0.00% |
IPGP | 51.27% | $2.80B | -22.33% | 0.00% |
VSH | 51.01% | $2.06B | -31.94% | 2.60% |
RVMD | 50.73% | $7.56B | +5.10% | 0.00% |
ROIV | 50.69% | $7.70B | +5.89% | 0.00% |
KYMR | 50.62% | $3.06B | +41.06% | 0.00% |
IRON | 50.35% | $1.86B | +16.08% | 0.00% |
KN | 50.31% | $1.46B | -4.00% | 0.00% |
BHVN | 50.22% | $1.58B | -54.30% | 0.00% |
BEAM | 49.46% | $1.72B | -31.40% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DFDV | 0.19% | $379.06M | +2,332.08% | 0.00% |
YORW | 0.29% | $464.84M | -10.03% | 2.66% |
VSA | 0.29% | $8.76M | -16.94% | 0.00% |
PPC | -0.30% | $10.94B | +49.72% | 0.00% |
DG | -0.42% | $24.58B | -11.22% | 2.12% |
PINC | -0.47% | $1.86B | +22.80% | 3.74% |
ZCMD | 0.52% | $29.04M | -3.36% | 0.00% |
STG | -0.58% | $29.38M | -15.04% | 0.00% |
K | -0.63% | $27.71B | +38.87% | 2.84% |
CME | -0.67% | $97.12B | +36.71% | 3.92% |
VZ | -0.82% | $181.34B | +8.42% | 6.31% |
LTM | -0.90% | $11.50B | -96.47% | 2.61% |
IMNN | 0.98% | $25.08M | +27.68% | 0.00% |
MSEX | 1.17% | $1.01B | +10.40% | 2.38% |
T | 1.19% | $202.84B | +59.81% | 3.95% |
FARO | -1.21% | $816.92M | +152.62% | 0.00% |
HUSA | 1.25% | $24.55M | +27.24% | 0.00% |
DUK | -1.29% | $90.83B | +14.17% | 3.57% |
PULM | -1.35% | $28.52M | +307.26% | 0.00% |
AEP | 1.47% | $54.97B | +16.93% | 3.56% |